BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Finance
Menlo Park Startup Armetheon Snags $7 Million Series A Financing 8/28/2014
Boston Startup OncoPep Secures $6.9 Million Series B Financing 8/28/2014
WaferGen Biosystems Announces Successful Completion Of Public Offering Raising $20 Million 8/28/2014
Fresh From Co-Founding Massively Financed Juno Therapeutics, Arch Venture Partners Banks $400 Million+ To Back New Biotechs 8/27/2014
Vaccinogen Plans Move To Baltimore After $80 Million In New Funding; Will Increase Headcount By 300 Percent 8/27/2014
Houston Biotech Bellicum Pharmaceuticals, Inc. Nabs $55 Million 8/27/2014
Zai Lab Of Shanghai Raises Over $30 Million In Series A Funding 8/27/2014
Redwood City Startup, Aldea Pharmaceuticals, Reels In $24 Million 8/26/2014
Massachusetts' Civitas Therapeutics Locks In $55 Million 8/26/2014
Viropro Inc. (VPRO) Initiates Interim Debt Financing Of Up To $500,000 8/26/2014
NEOMED Receives $12 Million From Federal Government 8/26/2014
FortuneRock (China) Hauls In $24 Million 8/25/2014
Vaccinogen Completes Initial Closing Of An $80 Million Financing 8/25/2014
Heat Biologics Closes On Up To $7.5 Million Secured Term Loan Facility 8/25/2014
Sprout Pharmaceuticals Eyes $15 Million From Private Investors To Develop Female Viagra 8/22/2014
NeuroDerm Ltd. Banks $16 Million 8/22/2014
Redwood City's Dermira Bags $51 Million, Expands Management Team And Board 8/20/2014
Emisphere Technologies, Inc. (EMIS) Announces $20 Million Debt Financing to Launch Oral Eligen® B12 8/20/2014
Bay Area's HealthQuest Capital Bags $110 Million For Debut Fund With Healthcare, Medtech Focus 8/19/2014
Redwood City's Comprehend Systems Bags $21 Million Series B Funding 8/18/2014
Switzerland-Based Santhera Pharmaceuticals AG (SANN.SW) Grabs CHF 13.4 Million 8/15/2014
Struggling Dendreon Corporation (DNDN) Plunges After Warning Investors Of Debt Woes 8/14/2014
Tarsa Therapeutics Secures $10 Million, Adds Industry Veteran As A Director 8/13/2014
Novartis AG (NVS), Siemens (SI), And Laboratory Corporation of America Holdings (LabCorp) (LH) Dumps $16 Million Into Seventh Sense Biosystems Inc. 8/13/2014
Synergy Healthcare plc (SYR) Invests 18 Million Gbp (Us$30 Million) To Expand Global Applied Sterilisation Technology Capacity 8/13/2014
Public Health Agency of Canada Release: Government Of Canada Donates Experimental Ebola Vaccine To World Health Organization 8/13/2014
Ortenzio Foundation & Select Medical (SLMC) Gift $1.25M To Kessler Foundation Neuroimaging & Rehab Research 8/13/2014
Biocryst Pharmaceuticals (BCRX) Receives Additional National Institute of Allergy And Infectious Diseases (NIAID) Funding To Advance Development Of BCX4430 To Treat Hemorrhagic Fever Virus Diseases 8/13/2014
G2B Pharma Receives Project Financing From Sosei Group Corporation And Right To In-License Nasal Delivery Technologies From SNBL 8/13/2014
Sirona (SIRO) Subsidiary, TFChem, Receives CDN$1.2 Million For Anti-Aging Project 8/12/2014
GenoSpace Announces Strategic Investment by Thomson Reuters 8/12/2014
Novogen Limited (NVGN) Receives Funding Support To Commence Studies In Muscular Dystrophy 8/12/2014
Acupera Raises Additional $4 Million for Population Health Platform 8/12/2014
FAAH Pharma Inc. Announces Investment From TVM Life Science Ventures VII To Develop New Treatment Against Neuropathic Pain 8/11/2014
TapImmune Inc. (TPIV) Announces $2 Million Registered Direct Offering 8/11/2014
Tolero Pharmaceuticals Bags $14.2 Million Series B Financing 8/8/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Scores $5.4 Million Private Financing 8/8/2014
Already-Rich Juno Therapeutics Reels In Another $134 Million, Has Raised $300 Million In Less Than 12 Months 8/6/2014
Innovus Pharma Secures Additional Funding By Increasing Its Line Of Credit With Its Chief Executive Officer To $1.5 Million, Provides Quarter Update And Timing Of Its 10-Q Filing 8/6/2014
Menlo Park's TesoRx Locks In $10 Million, Secures Key Patent And Taps Renowned Urologist As Chief Medical Officer 8/5/2014
IP Group Plc - Portfolio Company Diurnal Announces £6 Million Funding Round 8/5/2014
Perlstein Lab Raises $2 Million For Orphan Drug Discovery 8/5/2014
Biotech Startup Rebiotix Nabs $25 Million Series B 8/4/2014
GliaCure Closes On $5.8 Million Financing 8/4/2014
GE Foundation Announces $20 Million Commitment To Maternal And Child Health Programs In Africa 8/4/2014
Metabolix, Inc. Enters Into Private Placement Agreement With Investors To Raise $25 Million In Equity Financing 8/4/2014
National Cancer Institute Awards $7.3 Million To Kaiser Permanente For Cancer Clinical Trials, Patient Care Research 8/4/2014
VC Firm Venrock Locks In $450 Million To Invest In Tech And Life Sciences Startups 8/1/2014
Celladon Corporation Secures $25 Million Credit Facility From Hercules Growth Capital 8/1/2014
Lazarus Effect Closes $5 Million Financing 7/31/2014
Cambridge-Based Gen9 Gets $25 Million In Equity Funding For DNA Synthesis 7/31/2014
SoCal Biopharma Cold Genesys, Inc. Locks In $13.57 Million Series A 7/31/2014
Axxess Pharma, Inc. Secures $2 Million USD In Financing To Fulfill Increased Rate Of Purchase Orders 7/30/2014
Lightlake Therapeutics Inc. (LLTP) Receives Funding Commitment From A Prominent International Research And Development Foundation 7/30/2014
Four Biotech-Related Companies Sign Up For Start-Up NY Program, New Jobs Created 7/29/2014
Big Pharmas Such As Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), Pfizer Inc. (PFE) Pitch In On $51.1 Million Fund For New York City And Seattle Biotechs 7/29/2014
Amedisys (AMED) Announces New $70 Million Second Lien Credit Facility And Amendment To Senior Secured Credit Facility 7/29/2014
Bay Area's PaxVax, Inc. Reels In Up To $60 Million Financing 7/28/2014
Oregon Health & Science University (OHSU) Knight Cancer Challenge Attracts $100 Million Gift 7/28/2014
Oxford Finance Closes $8 Million Senior Debt Facility With Natrix Separations, Inc. 7/28/2014
Biodel Inc. (BIOD) Enters Into $15 Million Equity Commitment With Lincoln Park Capital 7/28/2014
New Cambridge-Based Biotech VC Firm Remiges BioPharma Emerges, Eyes $150 Million Fund 7/25/2014
Theraclion Receives €900 Thousand From Bpifrance's "Industrial Strategic Innovation" Program To Fund Development Of A New Treatment System In Collaboration With Supersonic Imagine 7/25/2014
Glaucoma Research Foundation Receives $1 Million Bequest From San Francisco Philanthropist Paul S. May 7/25/2014
Xention Limited Awarded £1.4m From Technology Strategy Board To Develop New Medicines For Atrial Fibrillation 7/24/2014
Atox Bio Locks In $23 Million 7/24/2014
Cambridge-Based Broad Institute To Receive Largest Gift Worldwide: $650 Million 7/23/2014
Mela Sciences (MELA) Announces $27.3 Million Private Placement Of Preferred Stock, Debentures And Warrants 7/23/2014
Taiho Pharmaceutical Invests US $30 Million In Remiges Biopharma Fund, LP 7/23/2014
Synlogic Secures $29.4 Million Series A Financing Led By Atlas Venture 7/22/2014
Skystar Bio-Pharmaceutical (CGPN) Of Xi’an Raises $5 Million 7/22/2014
StemCells Inc. (STEM) Announces Closing Of $20 Million Offering 7/21/2014
Cerecor Inc. Closes On Initial Tranche Of US $32 Million Series B Financing 7/21/2014
Phosphagenics Limited (POH.AX) Completes First Tranche of A $19.3 Million Capital Raising 7/21/2014
ZS Pharma (ZSPH) Secures $20 Million In Debt Financing 7/17/2014
Melanoma Research Foundation Release: Senate Appropriations Committee Increases Funding Available For Melanoma Research 7/17/2014
InflaRx Announces Successful Closing Of Its Round B Financing 7/17/2014
Infosys Co-founder Kris Gopalakrishnan Donates $1.8 Million To Carnegie Mellon University To Promote Brain Research And Education 7/17/2014
UrgentRx® Locks In $17.5 Million In Series C Funding 7/17/2014
Virobay Inc. Completes $8 Million Series B Preferred Stock Financing 7/16/2014
immatics biotechnologies GmbH Reels In €22 Million Series D 7/16/2014
Menlo Park's Virobay Inc. Completes $8 Million Series B Funding Round 7/16/2014
TONIX Pharmaceuticals, Inc. Announces Registered Direct Offering Of $7.8 Million 7/11/2014
Phosphagenics Limited (POH.AX) Locks In $19.3 Million Capital Raising 7/11/2014
Ocera Therapeutics, Inc. (OCRX) Raises $25.2 Million In Public Offering 7/10/2014
VC Firm Versant Ventures Closes In On $300 Million Fund For Medtech And Biotech 7/9/2014
Fund Manager Dumps Biggest Investment Into AstraZeneca PLC (AZN) 7/9/2014
Domainex Ltd Reports Success Of Its Lead Compound In Pre-Clinical Model Of COPD And Secures £1.4 Million Biomedical Catalyst Award 7/9/2014
Biosceptre International Limited Closes AUD 5 Million Financing From Existing Investors 7/9/2014
Chromatin, Inc.Secures $12.5 Million Credit Facility With The PrivateBank 7/9/2014
480 Biomedical Awarded $1 Million Phase II NHLBI Contract To Advance Bioresorbable Scaffold For Pediatric Pulmonary Artery Stenosis 7/9/2014
MabVax Therapeutics, Inc. Raises $3 Million In Common Stock Financing And An Additional $1.5 Million Upon Exercise Of Series C-1 Warrants 7/9/2014
DelMar Pharmaceuticals Receives Funding From The Canadian Federal Government 7/9/2014
National Institutes of Health (NIH) Funds Phase 2 Clinical Trial At University of California, Los Angeles (UCLA) For The Treatment Of ADHD With NeuroSigma, Inc.'s eTNS Systemnational 7/9/2014
Supernus Pharmaceuticals (SUPN) To Receive $30 Million In Non-Dilutive Royalty Deal 7/8/2014
National Institutes of Health (NIH) Has A New $248 Million Focus: Electroceuticals 7/7/2014
New York Couple Gifts Cold Spring Harbor Laboratory $50 Million For Biology Center 7/7/2014
ProSensa Holding N.V. (RNA) Files F-3 SEC Mixed Shelf Registration For Up To $150 Million 7/7/2014
Galapagos NV (GLPG.BR) Raises €1.9 Million Through Warrant Exercises 7/7/2014
Advanced Cell Technology Secures $30 Million Financing 7/3/2014
Zurex Pharma, Inc. Nabs $4 Million to Battle Hospital-Acquired Infections 7/3/2014
Akashi Therapeutics Receives Collective Funding Of $1.5 Million To Support HT-100 Clinical Development 7/3/2014
Massachusetts Startup Synchroneuron Nets $20 Million To Fund SNC-102 For Neuropsychiatric Disorders 7/2/2014
Novato's Raptor Pharmaceutical Inc. (RPTP) Reels In $70 Million 7/2/2014
Retrophin, Inc. (RTRX) Snags $91 Million 7/2/2014
Oxford Finance and Solar Capital Close $30 Million Senior Debt Facility With Radius (RDUS) 7/2/2014
Confirmed: With $32 Million, Boston Startup Morphs Into San Diego's Cidara Therapeutics 7/1/2014
South San Francisco's Tobira Therapeutics Inc. Wraps Up $15 Million Loan Agreement 7/1/2014
Menlo Park's Emerald Therapeutics Completes Latest Financing, Brings Total To $13.5 Million 7/1/2014
AstraZeneca PLC (AZN) CEO Wagers $3.4 Million On Shares 7/1/2014
uniQure Secures Additional $10 Million Venture Loan From Hercules Capital 7/1/2014
Karo Bio AB Granted 3.8 MSEK From Vinnova 7/1/2014
Sorrento Therapeutics, Inc. Awarded Up To $2.6 Million From The National Institutes of Health (NIH) For The Development Of New Anti-Bacterial Bispecific Antibodies And Antibody Formulated Drug Conjugates 7/1/2014
TrovaGene, Inc. Secures $15 Million In Debt Financing From Trojantec Ltd. And Oxford Finance 7/1/2014
Shire Gets $248 Million Tax Refund From Canada, More To Come 6/30/2014
To-BBB technologies BV Scrounges Up Euro 10 Million 6/30/2014
Actavis (ACT) Dumps $18 Million In New Warehouse Facilities 6/27/2014
Biotech-Focused VC Firm Polaris Targets $400 Million For 7th Fund 6/27/2014
DURECT Corporation (DRRX) Secures $20 Million Debt Financing 6/27/2014
SiEnergy Systems, LLC Awarded $2.65 Million As Part Of ARPA-E’s REBELS Program To Develop Innovative Distributed Generation Technologies 6/27/2014
Eighteen French Biotechs Such As Genticel And Genomic Vision Trek To New York To Hunt For American Investors 6/26/2014
Biotech Fraud-Detection Firm BioCatch Bags $10 Million In Funding 6/26/2014
Manchester's 4D Pharma Reels In $29 Million 6/26/2014
Cytomedix Inc. (CMXI) Completes The Second Tranche Of The $35 Million Convertible Debt Financing With Deerfield Management Company 6/26/2014
CrystalGenomics Nabs $12.8 Million From The Global Pharmaceutical Industry Development Fund 6/25/2014
HedgePath Pharmaceuticals Secures Interim Financing To Commence Clinical Trials And Finalizes Key Agreement With Mayne Pharma Limited 6/25/2014
Backed By New Investors Such As Lilly Ventures, Bay Area's Numerate Secures $8 Million 6/24/2014
TetraLogic Pharmaceuticals (TLOG) Announces Closing Of $47 Million Convertible Senior Notes Offering 6/24/2014
Cambridge Startup Dimension Therapeutics Reels In $30 Million Financing 6/23/2014
Oxitec Completes Oversubscribed £6.1 Million ($10.2 Million) Fundraising To Commercialise Pioneering Dengue Mosquito Control Technology 6/23/2014
Transition Therapeutics Inc. (TTH.TO) Announces Closing Of Private Placement Equity Financing 6/23/2014
Cambridge Startup Navitor Pharmaceuticals Debuts With $23.5 Million Series A In Pocket 6/20/2014
Los Angeles' Genzum Life Sciences Reels In $20 Million In Funding 6/20/2014
Dr. Reddy's Laboratories Ltd. (RDY) To Dump $320 Million In Biologics, Proprietary Medicines 6/20/2014
Horizon Biopharm In $300 Million Credit Agreement For Vidara Therapeutics Buy 6/19/2014
JHL Biotech Locks In $35 Million Series B Financing 6/19/2014
Tyrogenex, Inc. Nabs $15 Million Series D Financing 6/19/2014
Sidney Kimmel Foundation Gives $110 Million To Jefferson Medical College Of Thomas Jefferson University 6/19/2014
South San Francisco's True North Therapeutics Reels In $22 Million Series A Financing 6/18/2014
Western Oncolytics Receives $275,000 Seed Funding For Development Of Cancer Immunotherapy 6/18/2014
Valeant Pharmaceuticals International (VRX) Commences Exchange Offer For Allergan Inc. (AGN) 6/18/2014
Lakewood-Amedex Inc. Raises $5.5 Million In Series C Preferred Stock Financing 6/18/2014
TetraLogic Pharmaceuticals (TLOG) Announces Pricing Of $47 Million Offering Of Convertible Notes 6/18/2014
BioTime (BTX) Subsidiary Asterias Biotherapeutics Raises $13.0 Million In Equity Financing 6/17/2014
BioTime (BTX) Subsidiary Asterias Biotherapeutics Announces Investment By CEO 6/17/2014
AuraSense Therapeutics Completes $13.6 Million Series C Equity Investment 6/17/2014
Relmada Therapeutics Successfully Completes Offerings Totaling $28 Million In Connection With Going Public Transaction 6/16/2014
Berkeley's Aduro Biotech Reels In $55 Million Series C Financing 6/13/2014
CannLabs, Announces Reverse Merger And Commitment Of $1.25 Million In Funding 6/13/2014
BrainStorm Cell Therapeutics Inc. Raises $10.5 Million In Private Placement Financing 6/13/2014
Clarus Therapeutics Locks In $31.5 Million 6/12/2014
Cortexyme Raises Seed Funding, Awarded Breakout Labs Investment 6/12/2014
Health Integrated Secures $4 Million In Venture Debt Financing From Western Technology Investment 6/12/2014
RuiYi (formerly Anaphore) Closes $4 Million Venture Loan From Silicon Valley Bank 6/11/2014
Oxford Finance Closes $4 Million Debt Facility With IntelliCyt Corporation 6/11/2014
BioSilta Completes EUR 2.5 Million ($3.4 Million) Funding Round 6/11/2014
Merus Labs International Inc. Announces Aggregate $21 Million Financing Transactions 6/11/2014
As Its Investors Reap Returns, San Francisco's Venbio Aims For A Bigger Second Fund 6/10/2014
Nordic Nanovector Intends To Undertake Private Placement Of NOK 150 Million 6/6/2014
Transition Therapeutics Inc. (TTH.TO) Enters Into Deal With Investors To Receive Up To $30.8 Million 6/6/2014
Cytori Therapeutics, Inc. (CYTX) Closes Previously Announced $10 Million Offering 6/6/2014
Its First Drug In Clinic, Kineta Inc. Keeps Raising Cash From Odd Sources 6/5/2014
“Grindeks” Invests 2.4 Million Euros In Quality Control Laboratory 6/5/2014
Clinical Stage Biotech Trevi Therapeutics Brings In $25 Million Series B Financing 6/4/2014
Complexa Wraps Up $13 Million Series B Financing Round 6/4/2014
SteadyMed Announces Raise Of $19.6 Million In Preferred Stock Financing 6/4/2014
KemPharm, Inc. Bags $60 Million 6/3/2014
Nanotherapeutics Secures $30 Million Loan 6/3/2014
NeoStem, Inc. Accesses $30 Million Equity Facility With Aspire Capital 6/3/2014
Jubilant Pharma To Raise Over $100 Million, Plans To Consolidate Pharma Biz 6/2/2014
DefiniGEN Announces Closing Of £2.3 Million ($3.8 Million) Series A Fundraising 6/2/2014
Nuvilex (NVLX) Now Has Access To $50 Million With New Banking Agreement 6/2/2014
Relypsa, Inc. (RLYP) Secures Loan Facility Of Up To $35 Million 6/2/2014
Cambridge-Based Biotech Rodin Therapeutics Snags $12.9 Million Series A Financing 5/30/2014
Retrophin, Inc. (RTRX) Signs A $80 Million Term Loan And Convertible Note Issuing 5/30/2014
Cytori Therapeutics, Inc. (CYTX) To Raise $10 Million In Registered Direct Offering 5/30/2014
ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) (QGLY) Establishes 3.0 Million Share Equity Line 5/30/2014
Children's Hospital of Philadelphia Gene-Therapy Spinout Spark Therapeutics Hauls In $72.8 Million 5/29/2014
Redwood City Biotech ARMO BioSciences Locks Down $30 Million Series B 5/29/2014
Tarsa Therapeutics Reels In $7 Million To Prepare For Filing NDA For Ostora 5/29/2014
Evoke Pharma, Inc. Secures $4.5 Million Loan Facility With Square 1 Bank 5/29/2014
VC Firm Epidarex Capital Unveils £47.5 Fund For Early-Stage UK Startups, Spinouts 5/29/2014
Bay Area's Twist Bioscience Secures $31.1 Million 5/28/2014
San Francisco Biotech Startup Nurix Taps $25.1 Million Financing 5/27/2014
Crown Bioscience, Inc. Raises $26.6 Million In Series D Round 5/23/2014
OXiGENE (OXGN) Announces $16 Million At-The-Market Registered Direct Offering 5/23/2014
Mucosis B.V. Receives Financial Support From The Dutch Government For Its Syngem® Program 5/22/2014
Gene Therapy Biotech Lysogene Reels In $22 Million 5/21/2014
Roche (RHHBY) To Invest $135 Million Into Two New Manufacturing Facilities 5/21/2014
Lanthio Pharma Receives Dutch Government Loan Of Up To €3.6 Million To Develop Novel Therapy For Lung Fibrosis 5/21/2014
Chimerix, Inc. (CMRX) Looks To Rally Up $60 Million Partly To Pay For Drug Trial With Josh Hardy 5/20/2014
Redwood City's Coherus Biosciences Locks In $55 Million Series C 5/20/2014
Landmark Gift Of $100 Million From The Marie-Josée And Henry R. Kravis Foundation Will Support Groundbreaking Approach To Precision Oncology At Memorial Sloan-Kettering Cancer Center 5/20/2014
AmerisourceBergen Corporation (ABC) Okays Special $650 Million Special Share Repurchase Program 5/19/2014
Kymab Locks Down $40 Million For Antibody Research 5/16/2014
Proteon Therapeutics, Inc. Announces $45 Million Of Series D Financing 5/16/2014
Gelesis Expands Team To Advance Further Clinical Development Of Its Novel Obesity & Diabetes Therapy & Discloses Recent $12 Million Funding 5/16/2014
Sorbent Therapeutics, Inc. Closes $15 Million In First Tranche Of Series D 5/15/2014
Milestone Scientific (MS) Completes $10 Million Financing With A European Investing Group Specializing In High Potential Opportunities 5/15/2014
Xellia Pharmaceuticals Expands Croatian Product And Innovation R&D Center Of Excellence With Investment Of US$2.0 Million 5/14/2014